Email this article 
Post a Comment Possibilities of in vivo validation of a model of experimental osteoporosis
- Authors: Bairamov A.A.1,2, Mamina N.S.2, Karonova T.L.1, Shabanov P.D.3
-
Affiliations:
- V.A. Almazov Scientific Medical Research Centre
- Institute of Experimental Medicine
- Institute of Experimental Medicin
- Issue: Vol 18, No 4 (2020)
- Pages: 365-367
- Section: Short communications
- URL: https://bakhtiniada.ru/RCF/article/view/56967
- DOI: https://doi.org/10.17816/RCF184365-367
- ID: 56967
Cite item
Open Access
Access granted
Subscription Access
Abstract
In this work, the possibilities of in vivo validation of an experimental model of osteoporosis are analyzed. The model is based on the application of biochemical methods for analyzing predictors of osteoporosis in blood serum, and their informative value in the comparative analysis of the assessment of the degree of osteoporosis based on instrumental studies of autopsy of bone tissue using atomic absorption spectroscopy and x-ray densitometry.
Full Text
##article.viewOnOriginalSite##About the authors
Alekber A. Bairamov
V.A. Almazov Scientific Medical Research Centre; Institute of Experimental Medicine
Author for correspondence.
Email: nelya-mamina@yandex.ru
Dr. Med. Sci. (Pharmacology), Leading Researcher, Leading Researcher, Departmant of Neuropharmacology
Russian Federation, Saint PetersburgNailya Sh. Mamina
Institute of Experimental Medicine
Email: nelya-mamina@yandex.ru
Post-graduate student, Department of Neuropharmacology
Russian Federation, Saint PetersburgTatiana L. Karonova
V.A. Almazov Scientific Medical Research Centre
Email: karonova@mail.ru
Dr. Med. Sci. (Endocrinology), Head of the Laboratory of Clinical Endocrinology
Russian Federation, Saint PetersburgPetr D. Shabanov
Institute of Experimental Medicin
Email: pdshabanov@mail.ru
Dr. Med. Sci. (Pharmacology), Professor and Head, Department of Neuropharmacology
Russian Federation, Saint PetersburgReferences
- Патент на изобретение RU2582973C1. Байрамов А.А., Шабанов П.Д., Маевский Е.И., и др. Антиостеопорозное средство. [Patent RUS2582973C1. Bayramov AA, Shabanov PD, Maevskiy EI, et al. Antiosteoporoznoe sredstvo. (In Russ.)]
- Байрамов А.А., Маевский Е.И., Шабанов П.Д. Коррекция костного ремоделирования при экспериментальном остеопорозе // Обзоры по клинической фармакологии и лекарственной терапии. – 2019. – Т. 17. – № 4. – С. 43–50. [Bairamov AA, Maevsky EI, Shabanov PD. Correction of bone remodeling in experimental osteoporosis. Reviews on Clinical Pharmacology and Drug Therapy. 2019;17(4):43-50. (In Russ.)]. https://doi.org/10.17816/RCF17443-50.
- Левицкий А.П., Макаренко О.А., Деньга О.В., и др. Экспериментальные методы исследования стимуляторов остеогенеза: Методические рекомендации. – Киев: Авиценна, 2005. – С. 31–38. [Levitskiy AP, Makarenko OA, Den’ga OV, et al. Eksperimental’nye metody issledovaniya stimulyatorov osteogeneza: metodicheskie rekomendatsii. Kiev: Avitsenna; 2005. P. 31-38. (In Russ.)]
- Фролькис В.В., Поворознюк В.В., Евтушенко О.А., Григорьева Н.В. Экспериментальный остеопороз // Doctor. – 2003. – № 6. – С. 48–52. [Frol’kis V, Povoroznyuk V, Evtushenko O, Grigorieva N. Eksperimental’nyy osteoporoz. Doctor. 2003;(6):48-52. (In Russ.)]
